Results 31 to 40 of about 13,416 (164)

Clinical and Hematological Manifestation of Dengue Patients in 2022 Outbreak: A Tertiary Care Hospital‐Based Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 8, Issue 1, January 2025.
ABSTRACT Background and Aims Dengue is a mosquito‐borne viral disease that frequently causes seasonal outbreaks in Bangladesh, particularly during the monsoon months from June to September. Recent outbreaks have shown significant shifts in clinical manifestations, including changes in the timeframe and serotype mixing.
Md. Jubayer Hossain   +4 more
wiley   +1 more source

Monoclonal Antibodies as Immune Modulators for Cancer Therapy

open access: yesCanadian Journal of Infectious Diseases, 1992
Monoclonal antibodies may modulate immune and/or biological responses alone, or as carriers of specific agents. Monoclonal antibodies directed against tumours may be indirectly cytotoxic by modulation of antibody-dependent, cell-mediated cytotoxicity or ...
Robert O Dillman
doaj   +1 more source

Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling

open access: yesFrontiers in Immunology, 2022
Acting on the cytokine cascade is key to preventing disease progression and death in hospitalised patients with COVID-19. Among anti-cytokine therapies, interleukin (IL)-6 inhibitors have been the most used and studied since the beginning of the pandemic.
Gaetano Zizzo   +7 more
doaj   +1 more source

Current status of endoscopic ultrasound‐guided antitumor treatment for pancreatic cancer

open access: yesDigestive Endoscopy, Volume 37, Issue 1, Page 18-28, January 2025.
Endoscopic ultrasound (EUS) was developed in the 1990s and has significantly transformed pancreatic tumor diagnosis. Subsequently, EUS has rapidly shifted from being a purely diagnostic procedure to being used in a wide range of interventional procedures.
Kazuyuki Matsumoto   +3 more
wiley   +1 more source

Thioglycollate-elicited murine macrophages are cytotoxic to Mycoplasma arginini-infected YAC-1 tumor cells

open access: yesBrazilian Journal of Medical and Biological Research, 1998
Macrophages are important components of natural immunity involved in inhibition of tumor growth and destruction of tumor cells. It is known that these cells can be activated for tumoricidal activity by lymphokines and bacterial products.
F. Ribeiro-Dias   +5 more
doaj   +1 more source

Comprehensive Analysis Based on Genes Associated With Cuproptosis, Ferroptosis, and Pyroptosis for the Prediction of Diagnosis and Therapies in Coronary Artery Disease

open access: yesCardiovascular Therapeutics, Volume 2025, Issue 1, 2025.
Coronary artery disease (CAD) is a complex condition influenced by genetic factors, lifestyle, and other risk factors that contribute to increased mortality. This study is aimed at evaluating the diagnostic potential of genes associated with cuproptosis, ferroptosis, and pyroptosis (CFP) using network modularization and machine learning methods.
Yongyi Zhang   +11 more
wiley   +1 more source

Research progress of active polypeptides of Cordyceps militaris

open access: yesBIO Web of Conferences, 2017
It is recognized at home and abroad that Cordyceps militaris is a fungus that can be edible and used for medicinal application, and also a common cordyceps taishanensis that is widely distributed and with very high medicinal value in China.
Xu Guangyu   +5 more
doaj   +1 more source

The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart Allografts

open access: yesFrontiers in Immunology, 2018
The immune suppressants cyclosporin A (CsA) and tacrolimus (FK506) are used worldwide in transplantation medicine to suppress graft rejection. Both CsA and FK506 inhibit the phosphatase calcineurin (CN) whose activity controls the immune receptor ...
Johannes Baur   +12 more
doaj   +1 more source

Circulating Cytokine Levels and the Risk of Hypertrophic Scar: A Two‐Sample Mendelian Randomization Study

open access: yesDermatologic Therapy, Volume 2025, Issue 1, 2025.
Background: Chronic inflammation has been implicated in hypertrophic scar (HS) formation based on experimental evidence and clinical observations. However, the existence of a causal relationship between circulating cytokines and the risk of HS remains uncertain. This study aimed to elucidate whether genetically predicted circulating cytokine levels are
Xi Xu   +6 more
wiley   +1 more source

TIL Therapy in Lung Cancer: Current Progress and Perspectives

open access: yesAdvanced Science, Volume 11, Issue 46, December 11, 2024.
Unveiling the promise of Tumor‐Infiltrating Lymphocytes (TIL) therapy for lung cancer treatment. This review introduces why TIL therapy is suitable for lung cancer, delves into its historical and clinical developments, and discusses methods for identifying tumor‐recognizing TILs and optimizing TIL composition.
Weilei Hu, Yifei Bian, Hongbin Ji
wiley   +1 more source

Home - About - Disclaimer - Privacy